GeneDx (WGS) Stock Analysis
NASDAQHealthcareMedical - Diagnostics & Research
What GeneDx does
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Key metrics
ETFs linked to WGS
Broad-market and Healthcare sector ETFs an investor holding GeneDx is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how WGS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze WGS in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for GeneDx?
- GeneDx trades under the ticker WGS on NASDAQ.
- Which exchange is WGS listed on?
- WGS is listed on NASDAQ.
- What sector does GeneDx operate in?
- GeneDx is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
- How can PortView help analyze WGS in a portfolio?
- PortView shows WGS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.